Abstract:Successful in vivo gene delivery mediated by nonviral vectors requires efficient extracellular and intracellular gene delivery, but few studies have given attention to the former. That is why numerous gene delivery systems have succeeded in vitro, while the expected clinical success has not come about. To realize efficient extracellular gene delivery, the stability of vectors and/or their complexes with genes in body fluids is first required, which prevents loaded genes from premature unloading and degradation. Furthermore, the storage stability of vectors under common conditions is important for their widespread applications. Lipopolysaccharide-amine nanopolymersomes (NPs), a gene vector developed by our group recently, have higher than 95% in vitro transfection efficiency in mesenchymal stem cells when delivering pEGFP, and induce significant angiogenesis in zebrafish when delivering plasmid encoding vascular endothelial growth factor deoxyribonucleic acid (pVEGF). To reveal their extracellular delivery ability and storage stability, in this study their stability in various simulant physiological environments and storage conditions was systematically studied by monitoring their changes in disassembly, size, zeta potential, and transfection efficiency. Additionally, damage to the mitochondria of mesenchymal stem cells was evaluated. Results show that NPs and plasmid deoxyribonucleic acid (pDNA)-loaded NPs (pNPs) have acceptable stability against dilution, anions, salts, pH, enzyme, and serum, presumably assuring their efficient extracellular delivery in vivo. Moreover, both the lyophilized NPs at room temperature and NP/pNP solution at 4°C have high storage stability, and pNPs show low damage to the mitochondria. The acceptable stability of NPs combined with compatibility and efficient gene transfection highlight their huge potential in the clinic as a gene delivery vector.

[Biocompatibility of Poly-L-lysine-modified Silica Nanoparticles].

Polydopamine-based Nanoparticles with Excellent Biocompatibility for Photothermally Enhanced Gene Delivery

Poly-L-Lysine-Modified Silica Nanoparticles: A Potential Oral Gene Delivery System

Poly(L-lysine)-modified Silica Nanoparticles for the Delivery of Antisense Oligonucleotides.

Biocompatibility Assessment of Polyethylene Glycol-Poly L-Lysine-Poly Lactic-Co-Glycolic Acid Nanoparticles in Vitro and in Vivo

A Novel Nonviral Nanoparticle Gene Vector: Poly-L-lysine-silica Nanoparticles

Preparation and Biological Savety Evaluation of Silicon Nanoparticles for Gene Therapy

Biocompatibility Assessment Of Dnr-Peg-Pll-Plga Nanoparticles In Vitro And In Vivo

In Vitro Evaluation of the Genotoxicity of a Family of Novel MeO-PEG-poly(D,L-lactic-co-glycolic Acid)-Peg-ome Triblock Copolymer and PLGA Nanoparticles.

Preparation of Ε-Polylysine Modified Silica Nanoparticles

Investigation of PEG-PLGA-PEG Nanoparticles-based Multipolyplexes for IL-18 Gene Delivery

Improved Gene Transfer with Functionalized Hollow Mesoporous Silica Nanoparticles of Reduced Cytotoxicity.

Biocompatibility of mesoporous silica nanoparticles

Biocompatible Protamine Sulfate@Silicon Nanoparticle-Based Gene Nanocarriers Featuring Strong And Stable Fluorescence

Improved Gene Transfer by Functionalized Hollow Mesoporous Silica Nanoparticles with Low Cytotoxicity

Immunological properties of silica nanoparticles: a structure-activity relationship study

Novel cationic 6-lauroxyhexyl lysinate modified poly(lactic acid)-poly(ethylene glycol) nanoparticles enhance gene transfection.

Amino Acid-Linked Low Molecular Weight Polyethylenimine for Improved Gene Delivery and Biocompatibility

Amino-functionalized Mesoporous Silica Nanoparticles: Adsorption and Protection for Pcdna3.1(+)-Pkb-ha

Stability and Toxicity of Empty or Gene-Loaded Lipopolysaccharide-Amine Nanopolymersomes

Design, Synthesis and in Vitro Evaluation of A Novel "stealth" Polymeric Gene Vector